Sharps Technology Inc's fundamentals are relatively healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 148/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very low.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 22.00.In the medium term, the stock price is expected to trend down.The company has shown very weak stock market performance over the past month, in line with its fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Sharps Technology Inc's Score
Industry at a Glance
Industry Ranking
148 / 208
Overall Ranking
396 / 4582
Industry
Healthcare Equipment & Supplies
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
1
analysts
Buy
Current Rating
22.000
Target Price
+752.71%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Sharps Technology Inc Highlights
StrengthsRisks
Sharps Technology, Inc. is a medical device and pharmaceutical packaging company. The Company is engaged in offering patented smart-safety syringe products to the healthcare industry. The Company's smart safety syringe products, such as Securgard, Sologard, and Sharps Provensa, are ultra-low waste syringes that incorporate both passive and active safety and reuse prevention features. It Sharps Securegard and Sologard safety syringe product lines incorporate both active and passive safety features and have been designed to address the primary administration concerns with syringe delivery systems, including accidental needlestick injuries, wasted medicine/dead space and reuse prevention. It also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. It has a manufacturing facility in Hungary and is pursuing plans to expand its manufacturing capacity in the United States.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 0.00.
Overvalued
The company’s latest PE is -0.00, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 24.05K shares, decreasing 67.21% quarter-over-quarter.
Sharps Technology, Inc. is a medical device and pharmaceutical packaging company. The Company is engaged in offering patented smart-safety syringe products to the healthcare industry. The Company's smart safety syringe products, such as Securgard, Sologard, and Sharps Provensa, are ultra-low waste syringes that incorporate both passive and active safety and reuse prevention features. It Sharps Securegard and Sologard safety syringe product lines incorporate both active and passive safety features and have been designed to address the primary administration concerns with syringe delivery systems, including accidental needlestick injuries, wasted medicine/dead space and reuse prevention. It also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. It has a manufacturing facility in Hungary and is pursuing plans to expand its manufacturing capacity in the United States.
Ticker SymbolSTSS
CompanySharps Technology Inc
CEOMr. Robert M. Hayes
Websitehttps://sharpstechnology.com/
FAQs
What is the current price of Sharps Technology Inc (STSS)?
The current price of Sharps Technology Inc (STSS) is 2.220.
What is the symbol of Sharps Technology Inc?
The ticker symbol of Sharps Technology Inc is STSS.
What is the 52-week high of Sharps Technology Inc?
The 52-week high of Sharps Technology Inc is 690.000.
What is the 52-week low of Sharps Technology Inc?
The 52-week low of Sharps Technology Inc is 2.210.
What is the market capitalization of Sharps Technology Inc?
The market capitalization of Sharps Technology Inc is 61.33M.
What is the net income of Sharps Technology Inc?
The net income of Sharps Technology Inc is -9.30M.
Is Sharps Technology Inc (STSS) currently rated as Buy, Hold, or Sell?
According to analysts, Sharps Technology Inc (STSS) has an overall rating of Buy, with a price target of 22.000.
What is the Earnings Per Share (EPS TTM) of Sharps Technology Inc (STSS)?
The Earnings Per Share (EPS TTM) of Sharps Technology Inc (STSS) is -873.265.